UNSPSC 51141595: Nafimidone hydrochloride

This classification denotes an anticonvulsant agent with the molecular formula C15H12N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LU0A7HD640, chemically known as 2-acetonaphthone, 2-(1-imidazolyl)-, hydrochloride but more generally known as nafimidone hydrochloride, which bears US NIH Compound Identifier 51199. Most nations, for tariff and trade purposes, schedule nafimidone hydrochloride under HS 29332990 and SITC 51573. As of Q4 2014, NAFIMIDONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Nafimidone hydrochloride bears US NLM identifiers UMLS ID C2983843 and NCI Concept Code C90708. SMILES: C1CCC2CC(CCC2C1)C(=O)CN3CCNC3.CL.

UNSPSC 51141595 Nafimidone hydrochloride is a Commodity code that describes a specific pharmaceutical compound, but recent state and local procurement activity under this code shows little alignment with the code's nominal scope. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems rather than nafimidone hydrochloride, a mismatch that suggests either miscoding in the procurement system or minimal actual demand for nafimidone hydrochloride itself among state and local buyers. State and local government procurement under this code appears to be sparse or inactive; the source does not support a pattern of issuing bodies, repeat buyers, or a broad mix of jurisdictions soliciting the compound.

Seminole County, Florida is the only jurisdiction represented in recent activity. The county released IFB60459723LAS on June 30, 2026 (with a response deadline of July 26, 2023, indicating a data-source anomaly), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding. Quarterly deliveries are to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for shipping and all associated costs. The contract carries a two-year initial term with an optional one-year renewal, and vendors must comply with E-Verify, drug-free workplace certification, and standard insurance requirements. The narrow geographic and issuing-body footprint, combined with the mismatch between the code name and the actual goods being purchased, suggests this code warrants a watch posture rather than active pursuit at this time.